4//SEC Filing
Gurrola Sandra M 4
Accession 0001641172-25-018063
CIK 0000748592other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 8:00 PM ET
Size
7.4 KB
Accession
0001641172-25-018063
Insider Transaction Report
Form 4
Gurrola Sandra M
VP of Finance
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-06-21+30→ 0 total→ Common Stock (30 underlying) - Exercise/Conversion
Common Stock
2025-06-21+30→ 110 total
Footnotes (2)
- [F1]Each restricted stock unit converts into one share of common stock.
- [F2]On June 21, 2021, the reporting person was granted 118 restricted stock units, vesting in four substantially equal installments beginning on the first anniversary of the grant date.
Documents
Issuer
Ernexa Therapeutics Inc.
CIK 0000748592
Entity typeother
Related Parties
1- filerCIK 0001618457
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 8:00 PM ET
- Size
- 7.4 KB